393 related articles for article (PubMed ID: 35955628)
1. Stem Cell-Based Therapies for Inflammatory Bowel Disease.
Zhang HM; Yuan S; Meng H; Hou XT; Li J; Xue JC; Li Y; Wang Q; Nan JX; Jin XJ; Zhang QG
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955628
[TBL] [Abstract][Full Text] [Related]
2. The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy.
Binienda A; Ziolkowska S; Hauge IH; Salaga M
Curr Drug Targets; 2020; 21(14):1405-1416. PubMed ID: 32364073
[TBL] [Abstract][Full Text] [Related]
3. Management of Inflammatory Bowel Disease Using Stem Cell Therapy.
Irhimeh MR; Cooney J
Curr Stem Cell Res Ther; 2016; 11(1):72-7. PubMed ID: 26216128
[TBL] [Abstract][Full Text] [Related]
4. Therapy with stem cells in inflammatory bowel disease.
Martínez-Montiel Mdel P; Gómez-Gómez GJ; Flores AI
World J Gastroenterol; 2014 Feb; 20(5):1211-27. PubMed ID: 24574796
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease: Moving toward a stem cell-based therapy.
Lanzoni G; Roda G; Belluzzi A; Roda E; Bagnara GP
World J Gastroenterol; 2008 Aug; 14(29):4616-26. PubMed ID: 18698675
[TBL] [Abstract][Full Text] [Related]
6. Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges.
Tian CM; Zhang Y; Yang MF; Xu HM; Zhu MZ; Yao J; Wang LS; Liang YJ; Li DF
J Inflamm Res; 2023; 16():2089-2119. PubMed ID: 37215379
[TBL] [Abstract][Full Text] [Related]
7. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
Adak S; Mukherjee S; Sen D
Curr Stem Cell Res Ther; 2017; 12(8):644-657. PubMed ID: 28914206
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
[TBL] [Abstract][Full Text] [Related]
10. Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More.
Misselwitz B; Juillerat P; Sulz MC; Siegmund B; Brand S;
Digestion; 2020; 101 Suppl 1():69-82. PubMed ID: 32570252
[TBL] [Abstract][Full Text] [Related]
11. Systematic Exposition of Mesenchymal Stem Cell for Inflammatory Bowel Disease and Its Associated Colorectal Cancer.
Kang J; Zhang L; Luo X; Ma X; Wang G; Yang Y; Yan Y; Qian H; Zhang X; Xu W; Mao F
Biomed Res Int; 2018; 2018():9652817. PubMed ID: 30687760
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in inflammatory bowel disease: Novel and emerging treatments.
Catalan-Serra I; Brenna Ø
Hum Vaccin Immunother; 2018; 14(11):2597-2611. PubMed ID: 29624476
[TBL] [Abstract][Full Text] [Related]
13. The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children.
Mutalib M; Borrelli O; Blackstock S; Kiparissi F; Elawad M; Shah N; Lindley K
J Crohns Colitis; 2014 Dec; 8(12):1730-4. PubMed ID: 25240477
[TBL] [Abstract][Full Text] [Related]
14. Organoid-based regenerative medicine for inflammatory bowel disease.
Okamoto R; Shimizu H; Suzuki K; Kawamoto A; Takahashi J; Kawai M; Nagata S; Hiraguri Y; Takeoka S; Sugihara HY; Yui S; Watanabe M
Regen Ther; 2020 Mar; 13():1-6. PubMed ID: 31970266
[TBL] [Abstract][Full Text] [Related]
15. Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.
Zhang X; Wang S; Ding X; Guo J; Tian Z
Scand J Immunol; 2020 Sep; 92(3):e12897. PubMed ID: 32443180
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.
Ko JZ; Johnson S; Dave M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440772
[TBL] [Abstract][Full Text] [Related]
17. Investigating cell therapy for inflammatory bowel disease.
Okamoto R; Watanabe M
Expert Opin Biol Ther; 2016 Aug; 16(8):1015-23. PubMed ID: 27113391
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy.
Mishra R; Dhawan P; Srivastava AS; Singh AB
World J Stem Cells; 2020 Oct; 12(10):1050-1066. PubMed ID: 33178391
[TBL] [Abstract][Full Text] [Related]
19. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for CYBB heterozygous mutation resulting in very early onset inflammatory bowel disease in children: a case report.
Li Z; Chen H; Feng X; Ruan Y; Yang M
BMC Pediatr; 2023 Jul; 23(1):348. PubMed ID: 37434114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
